Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

iSpecimen (ISPC) Total Current Liabilities (2020 - 2025)

iSpecimen has reported Total Current Liabilities over the past 6 years, most recently at $6.2 million for Q4 2025.

  • For Q4 2025, Total Current Liabilities rose 7.99% year-over-year to $6.2 million; the TTM value through Dec 2025 reached $6.2 million, up 7.99%, while the annual FY2025 figure was $6.2 million, 7.99% up from the prior year.
  • Total Current Liabilities for Q4 2025 was $6.2 million at iSpecimen, up from $5.7 million in the prior quarter.
  • Over five years, Total Current Liabilities peaked at $6.3 million in Q3 2024 and troughed at $2.0 million in Q2 2022.
  • A 5-year average of $4.4 million and a median of $4.9 million in 2025 define the central range for Total Current Liabilities.
  • Biggest five-year swings in Total Current Liabilities: plummeted 88.68% in 2021 and later skyrocketed 103.25% in 2024.
  • Year by year, Total Current Liabilities stood at $2.5 million in 2021, then surged by 70.87% to $4.3 million in 2022, then skyrocketed by 41.29% to $6.0 million in 2023, then decreased by 4.6% to $5.8 million in 2024, then increased by 7.99% to $6.2 million in 2025.
  • Business Quant data shows Total Current Liabilities for ISPC at $6.2 million in Q4 2025, $5.7 million in Q3 2025, and $5.2 million in Q2 2025.